Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.

Aykan, Faruk; Sevinc, Alper; Akbulut, Hakan; Yuce, Deniz; Hayran, Mutlu; Kilickap, Saadettin; Demirag, Guzin; Coskun, Hasan Senol; Karabulut, Bulent; Evrensel, Turkkan; Ustaoglu, Mehmet Ali; Ozdemir, Feyyaz; Turna, Hande; Yavuzsen, Tugba; Yalcin, Suayib; Dane, Faysal; Oksuzoglu, Berna; Yildirim, Nuriye; Isikdogan, Abdurrahman; Ozkan, Metin

dc.contributor.author	Aykan, Faruk
dc.contributor.author	Sevinc, Alper
dc.contributor.author	Akbulut, Hakan
dc.contributor.author	Yuce, Deniz
dc.contributor.author	Hayran, Mutlu
dc.contributor.author	Kilickap, Saadettin
dc.contributor.author	Demirag, Guzin
dc.contributor.author	Coskun, Hasan Senol
dc.contributor.author	Karabulut, Bulent
dc.contributor.author	Evrensel, Turkkan
dc.contributor.author	Ustaoglu, Mehmet Ali
dc.contributor.author	Ozdemir, Feyyaz
dc.contributor.author	Turna, Hande
dc.contributor.author	Yavuzsen, Tugba
dc.contributor.author	Yalcin, Suayib
dc.contributor.author	Dane, Faysal
dc.contributor.author	Oksuzoglu, Berna
dc.contributor.author	Yildirim, Nuriye
dc.contributor.author	Isikdogan, Abdurrahman
dc.contributor.author	Ozkan, Metin
dc.date.accessioned	2021-03-04T13:22:36Z
dc.date.available	2021-03-04T13:22:36Z
dc.identifier.citation	Yalcin S., Dane F., Oksuzoglu B., Yildirim N., Isikdogan A., Ozkan M., Demirag G., Coskun H. S. , Karabulut B., Evrensel T., et al., "Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.", Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36
dc.identifier.other	vv_1032021
dc.identifier.other	av_7c229cb3-0bb0-4630-be68-04191604068e
dc.identifier.uri	http://hdl.handle.net/20.500.12627/84896
dc.identifier.uri	https://doi.org/10.1200/jco.2018.36.4_suppl.346
dc.language.iso	eng
dc.subject	Klinik Tıp (MED)
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.title	Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	36
dc.contributor.firstauthorID	152996

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster